logo
Plus   Neg
Share
Email

Stock Alert:Dr. Reddy's Laboratories Touches New High

Dr. Reddy's Laboratories Limited (RDY) touched a new high of $49.27 on Monday, April 13, before closing at $49.10, up 4.91%.

Monday, Dr. Reddy's launched Invista for the treatment of chronic accelerated or myeloid or lymphoid blast phase and newly diagnosed in chronic phase adult patients with Chronic Myeloid Leukemia (CML) in India.

Invista is a formulation of Dasatinib that is bio equivalent to the innovator brand. Indian Patent on Bristol-Myers-Squibb's Dasatinib was expired on April 12.

Dr.Reddy's has been ticking up from March 18, after touching 52-week low of $33.33. It has gained nearly 50% in less than a month

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Flagstone Foods LLC is recalling certain Wegmans Pecan Blend Trail Mix citing the possible presence of undeclared almonds and walnuts, the U.S. Food and Drug Administration announced. The Robersonville, North Carolina-based company initiated the recall following a notification from a customer that the product contained almonds and walnuts that are not listed in the ingredient statement on the pack Ford has revived the iconic Bronco brand after a gap of 24 years, this time as a dedicated off-road brand aiming to take on Fiat Chrysler's Jeep Wrangler, the dominant vehicle in the off-road category. Ford has introduced three new vehicles under the all-new Bronco brand as a 4x4 family of rugged SUVs under the tagline, "Built Wild". 3M Co. is teaming with researchers at Massachusetts Institute of Technology or MIT to develop a new rapid antigen test that detects the COVID-19 virus. The research, being conducted at the pilot lab facility at 3M's headquarters in St. Paul, Minnesota, is to learn if a simple-to-use, diagnostic device can produce highly accurate results within minutes and is feasible to mass manufacture.
Follow RTT